Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-12 Sale |
2021-05-12 8:53 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,200 | $11.09 | $13,308 | 1,354,762 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-06 5:28 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,200 | $11.3 | $13,560 | 1,355,962 (Direct) |
View |
| 2021-04-28 Sale |
2021-04-30 5:52 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
2,400 | $12.58 | $30,192 | 1,357,162 (Direct) |
View |
| 2021-04-26 Sale |
2021-04-27 7:59 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
600 | $13 | $7,800 | 1,359,562 (Direct) |
View |
| 2021-04-21 Sale |
2021-04-22 5:11 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $11.98 | $21,564 | 1,360,162 (Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 7:08 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $12.22 | $21,996 | 1,361,962 (Direct) |
View |
| 2021-04-07 Sale |
2021-04-08 7:06 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $12.02 | $21,636 | 1,363,762 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 8:37 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
600 | $13 | $7,800 | 1,365,562 (Direct) |
View |
| 2021-03-31 Sale |
2021-04-02 5:21 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $11.96 | $21,528 | 1,366,162 (Direct) |
View |
| 2021-03-22 Sale |
2021-03-24 6:48 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
2,400 | $11.96 | $28,716 | 1,367,962 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-18 8:45 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,200 | $11.36 | $13,632 | 1,370,362 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-18 8:44 pm |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
6,497 | $11.01 | $71,556 | 71,503 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-11 4:14 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $11.97 | $21,540 | 1,371,562 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 6:52 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
1,800 | $11.87 | $21,360 | 1,373,362 (Direct) |
View |
| 2021-02-24 Sale |
2021-02-25 8:17 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
2,400 | $12.36 | $29,652 | 1,375,162 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-18 4:20 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
2,400 | $12.7 | $30,480 | 1,377,562 (Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 4:23 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
3,000 | $14.2 | $42,600 | 1,379,962 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:41 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
600 | $14 | $8,400 | 1,382,962 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-05 4:51 pm |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
2,400 | $13.23 | $31,752 | 1,383,562 (Direct) |
View |
| 2020-07-07 Purchase |
2020-12-23 7:31 pm |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
424,000 | $15.25 | $6,466,000 | 14,989,221 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-11 Option Award |
2021-05-13 5:38 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | SIMPSON TODD E Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:37 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:37 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin M. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:36 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:23 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2021-04-30 Option Award |
2021-05-04 4:35 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer |
495,000 | $0 | 495,000 (Direct) |
View |
| 2021-03-16 Exercise |
2021-03-18 8:44 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
25,000 | $0 | 71,503 (Direct) |
View |
| 2021-01-30 Option Award |
2021-02-02 4:11 pm |
N/A 2031-01-30 |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2021-02-02 4:10 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President |
0 | $0 | 2,035,962 (Direct) |
View |
| 2020-10-19 Option Award |
2020-10-20 6:15 pm |
N/A 2030-10-19 |
Neoleukin Therapeutics Inc. | NLTX | Vance Holly General Counsel |
220,000 | $0 | 220,000 (Direct) |
View |
| 2020-09-08 Option Award |
2020-09-10 4:28 pm |
N/A 2030-09-08 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-08-10 Option Award |
2020-08-12 4:10 pm |
N/A 2030-08-10 |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2020-08-10 Option Award |
2020-08-12 4:08 pm |
N/A 2030-08-10 |
Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO |
420,000 | $0 | 420,000 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 4:30 pm |
N/A 2030-06-01 |
Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin M. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-07 5:16 pm |
N/A 2030-05-04 |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN 667 L.P. Baker Bros. Advisors (GP) LLC Director |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2020-05-05 Option Award |
2020-05-07 4:28 pm |
N/A 2030-05-05 |
Neoleukin Therapeutics Inc. | NLTX | Williams Lewis T Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-07 4:27 pm |
N/A 2030-05-05 |
Neoleukin Therapeutics Inc. | NLTX | SIMPSON TODD E Director |
25,000 | $0 | 25,000 (Direct) |
View |